Treatment of Anemia in Patients With Very Low, Low or Intermediate Risk Myelodysplastic Syndromes With CA-4948

NCT05178342 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

38

Enrollment

OTHER

Sponsor class

Stopped Prematurely according to trial protocol

Conditions

Myelodysplastic Syndromes
Anemia

Interventions

DRUG: CA-4948

Sponsor

University of Leipzig

Collaborators

[object Object]